Patrick Smith is a partner in Gowlings' Ottawa office and a member of the firm’s National Practice Group for Patents and Life Sciences. Patrick is also a registered patent agent in Canada. He is ranked in The Best Lawyers in Canada and IAM Patent 1000 and the 2013 edition of IAM 1000 (The World’s Leading Patent Practitioners) described him as “aggressive, experienced and technically savvy” and “one of the busiest litigators around, appearing as lead counsel in a wide range of conflicts."
Patrick provides strategic patent, trade-mark, regulatory and life cycle advice to clients in the oil and gas, pharmaceutical, agriculture, biotech and chemical industries.
Patrick has appeared as counsel in more than 100 reported decisions relating to patents, trade-marks and copyright in the Ontario Court, Federal Court and Supreme Court of Canada. His two recent appearances in the Supreme Court of Canada were Teva v. Pfizer (2012) and AstraZeneca v. Canada (2006).
He has successfully represented clients such as Baker Petrolite, Eli Lilly, Pfizer, Merck, Janssen, Schering-Plough, Bristol-Myers Squibb, Dow AgroSciences, Allergan, Bayer, Purdue Pharmaceuticals and Amgen in all levels of Court on litigation matters.
Patrick is a regular writer and speaker on key IP issues impacting companies operating in Canada. He is a former adjunct professor of law at the University of Ottawa and now mentors students, associates and junior partners at the firm.